1). Parfrey PS, Bear JC, Morgan J, Cramer BC, McMana-mon PJ, Gault MH, et al. The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med. 1990; 323:1085–90.
Article
2). Singh S, Hariharan S. Renal replacement therapy in autosomal dominant polycystic kidney disease. Nephron. 1991; 57:40–4.
Article
3). Beyea SC. Anticoagulants: be alert for errors. AORN J. 2009; 89:203–5.
Article
4). Cohen D, Timsit MO, Chretien Y, Thiounn N, Vassiliu V, Mamzer MF, et al. Place of nephrectomy in patients with autosomal dominant polycystic kidney disease waiting for renal transplantation. Prog Urol. 2008; 18:642–9.
5). Bendavid Y, Moloo H, Klein L, Burpee S, Schlachta CM, Poulin EC, et al. Laparoscopic nephrectomy for autosomal dominant polycystic kidney disease. Surg Endosc. 2004; 18:751–4.
Article
6). Rozanski J, Kozlowska I, Myslak M, Domanski L, Sienko J, Ciechanowski K, et al. Pretransplant nephrectomy in patients with autosomal dominant polycystic kidney disease. Transplant Proc. 2005; 37:666–8.
Article
7). Hong JS, Kim SJ, Lee SK, Joh JW, Kwon CH, Choi GS, et al. Sequential vs. simultaneous bilateral native nephrectomy and renal transplantation for autosomal dominant polycystic kidney disease. J Korean Soc Transplant. 2008; 22:248–53. (홍지선, 김성주, 이석구, 조재원, 권준혁, 최규성, 등. 상염색체 우성 다낭신 환자에서 신장이식과 동시 혹은 순차 양측 신장절제술. 대한이식학회지 2008;22: 248–53.).
8). Kramer A, Sausville J, Haririan A, Bartlett S, Cooper M, Phelan M. Simultaneous bilateral native nephrectomy and living donor renal transplantation are successful for polycystic kidney disease: the University of Maryland experience. J Urol. 2009; 181:724–8.
Article
9). Lipke MC, Bargman V, Milgrom M, Sundaram CP. Limitations of laparoscopy for bilateral nephrectomy for autosomal dominant polycystic kidney disease. J Urol. 2007; 177:627–31.
Article
10). Ismail HR, Flechner SM, Kaouk JH, Derweesh IH, Gill IS, Modlin C, et al. Simultaneous vs. sequential laparoscopic bilateral native nephrectomy and renal transplantation. Transplantation. 2005; 80:1124–7.
Article
11). Florijn KW, Chang PC, van der Woude FJ, van Bockel JH, van Saase JL. Long-term cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease patients after renal transplantation. Transplantation. 1994; 57:73–81.
Article
12). Choukroun G, Itakura Y, Albouze G, Christophe JL, Man NK, Grunfeld JP, et al. Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1995; 6:1634–42.
Article
13). Ho-Hsieh H, Novick AC, Steinmuller D, Streem SB, Buszta C, Goormastic M. Renal transplantation for end stage polycystic kidney disease. Urology. 1987; 30:322–6.
14). Knispel HH, Klan R, Offermann G, Miller K. Transplantation in autosomal dominant polycystic kidney disease without nephrectomy. Urol Int. 1996; 56:75–8.
Article
15). Sulikowski T, Tejchman K, Zietek Z, Rozanski J, Domanski L, Kaminski M, et al. Experience with autosomal dominant polycystic kidney disease in patients before and after renal transplantation: a 7-year observation. Transplant Proc. 2009; 41:177–80.
Article
16). Perico N, Antiga L, Caroli A, Ruggenenti P, Fasolini G, Cafaro M, et al. Sirolimus therapy to halt the progression of ADPKD. J Am Soc Nephrol. 2010; 21:1031–40.
Article
17). Torres VE, Boletta A, Chapman A, Gattone V, Pei Y, Qian Q, et al. Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases. Clin J Am Soc Nephrol. 2010; 5:1312–29.
Article
18). Watnick T, Germino GG. mTOR Inhibitors in polycystic kidney disease. N Engl J Med. 2010; 363:879–81.
Article
19). Ubara Y, Tagami T, Sawa N, Katori H, Yokota M, Takemoto F, et al. Renal contraction therapy for enlarged polycystic kidneys by transcatheter arterial embolization in hemodialysis patients. Am J Kidney Dis. 2002; 39:571–9.
Article
20). Cornelis F, Couzi L, Le Bras Y, Hubrecht R, Dodre E, Genevieve M, et al. Embolization of polycystic kidneys as an alternative to nephrectomy before renal transplantation: a pilot study. Am J Transplant. 2010; 10:2363–9.
Article